Bruker Corp. Stock
Price
Target price
€54.05
€54.05
5.540%
2.73
5.540%
€51.52
03.06.26 / Tradegate
WKN: 813534 / Symbol: BRKR / Name: Bruker / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Bruker Corp. Stock
Bruker Corp. dominated the market today, gaining €2.73 (5.540%).
With 13 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
However, we have a potential of -5.64% for Bruker Corp. as the target price of 51 € is below the current price of 54.05 €.
For the coming years our community has positive and negative things to say abot the Bruker Corp. stock. Criterium "Revenue growth" gathered the most positive votes but regarding "Revenue growth" there were negative voices in the community.
Pros and Cons of Bruker Corp. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bruker Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bruker Corp. | 5.540% | 29.229% | 72.794% | 64.336% | 32.508% | -19.328% | - |
| Healthequity Inc. | 0.000% | 1.351% | 7.914% | -15.254% | -3.846% | 45.631% | 11.607% |
| Omnicell Inc. | -1.670% | -3.804% | 0.568% | 31.111% | -8.763% | -48.321% | -68.393% |
| Myriad Genetics | 0.110% | 10.377% | -8.161% | -3.880% | -30.358% | -83.069% | -83.574% |
Comments
Bruker (BRKR) had its price target lowered by Barclays PLC from $50.00 to $45.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (BRKR) had its price target lowered by Guggenheim from $58.00 to $50.00. They now have a "buy" rating on the stock.
Show more
Ratings data for BRKR provided by MarketBeat
Bruker (NASDAQ:BRKR) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Show more
Ratings data for BRKR provided by MarketBeat
News
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million
